Laurence A. Turka

Insider Reports History

Entity
Individual
Location
C/O Rubius Therapeutics, Inc., 399 Binney St., Suite 300, Cambridge, MA
Signature
/s/ Jennifer Kamocsay, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Laurence A. Turka:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Rubius Therapeutics, Inc. Chief Scientific Officer Restricted Stock Units 25.9K Jan 31, 2023 Direct
Rubius Therapeutics, Inc. Chief Scientific Officer Common Stock 18.4K Jan 31, 2023 Direct

Insider Reports Filed by Laurence A. Turka

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RUBY Rubius Therapeutics, Inc. Jan 29, 2023 5 -$622 4 Jan 31, 2023 Chief Scientific Officer
RUBY Rubius Therapeutics, Inc. Jan 29, 2022 5 -$16.5K 4 Feb 1, 2022 Chief Scientific Officer